1
|
Diniz H, Bandeira M, Teresa A, Besteiro B, Coimbra J, Gomes F and Sampaio S: IgA nephropathy with thrombotic microangiopathy: Is this secondary thrombotic microangiopathy or IgA nephropathy-triggered atypical Hemolytic Uremic Syndrome? Portuguese J Nephrol Hypertension. 33:239–243. 2019.
|
2
|
Barratt J and Feehally J: IgA nephropathy. J Am Soc Nephrol. 16:2088–2097. 2005.PubMed/NCBI View Article : Google Scholar
|
3
|
Smith AC and Feehally J: New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy. Springer Semin Immunopathol. 24:477–493. 2003.PubMed/NCBI View Article : Google Scholar
|
4
|
Galla JH: IgA nephropathy. Kidney Int. 47:377–387. 1995.PubMed/NCBI View Article : Google Scholar
|
5
|
Schwartz D and Pullman J: Renal biopsy in pregnancy: Risks, benefits, pathologic findings, and illustrative examples. In: Obstetric and Gynecologic Nephrology. Springer, pp87-99, 2020.
|
6
|
Bandari J, Fuller TW, Ii RM and D'Agostino LA: Renal biopsy for medical renal disease: Indications and contraindications. Can J Urol. 23:8121–8126. 2016.PubMed/NCBI
|
7
|
Sumnu A, Gursu M and Ozturk S: Primary glomerular diseases in the elderly. World J Nephrol. 4:263–270. 2015.PubMed/NCBI View Article : Google Scholar
|
8
|
Xu DM, Chen M, Zhou FD and Zhao MH: Risk factors for severe bleeding complications in percutaneous renal biopsy. Am J Med Sci. 353:230–235. 2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Zhu MS, Chen JZ and Xu AP: Factors that can minimize bleeding complications after renal biopsy. Int Urol Nephrol. 46:1969–1975. 2014.PubMed/NCBI View Article : Google Scholar
|
10
|
Hollis EM: Diffusion-Weighted magnetic resonance imaging in diagnosing graft dysfunction: A non-invasive alternative to renal biopsy. Electronic Theses and Dissertations, 2017 https://doi.org/10.18297/etd/2661.
|
11
|
Silberring J and Ciborowski P: Biomarker discovery and clinical proteomics. Trends Analyt Chem. 29(128)2010.PubMed/NCBI View Article : Google Scholar
|
12
|
Graterol F, Navarro-Muñoz M, Ibernon M, López D, Troya MI, Pérez V, Bonet J and Romero R: Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling. BMC Nephrol. 14(82)2013.PubMed/NCBI View Article : Google Scholar
|
13
|
Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H and Mischak H: Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 67:2313–2320. 2005.PubMed/NCBI View Article : Google Scholar
|
14
|
Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, et al: Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis. 28:4469–4483. 2007.PubMed/NCBI View Article : Google Scholar
|
15
|
Kaneshiro N, Xiang Y, Nagai K, Kurokawa MS, Okamoto K, Arito M, Masuko K, Yudoh K, Yasuda T, Suematsu N, et al: Comprehensive analysis of short peptides in sera from patients with IgA nephropathy. Rapid Commun Mass Spectrom. 23:3720–3728. 2009.PubMed/NCBI View Article : Google Scholar
|
16
|
Rocchetti MT, Papale M, d'Apollo AM, Suriano IV, Di Palma AM, Vocino G, Montemurno E, Varraso L, Grandaliano G, Di Paolo S and Gesualdo L: Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. Clin J Am Soc Nephrol. 8:1115–1125. 2013.PubMed/NCBI View Article : Google Scholar
|
17
|
Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K and Chen X: Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun Mass Spectrom. 24:1971–1978. 2010.PubMed/NCBI View Article : Google Scholar
|
18
|
Zurbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL and Schanstra JP: The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics. 9:2108–2117. 2009.PubMed/NCBI View Article : Google Scholar
|
19
|
Baum F, Fedorova M, Ebner J, Hoffmann R and Pischetsrieder M: Analysis of the endogenous peptide profile of milk: Identification of 248 mainly casein-derived peptides. J Proteome Res. 12:5447–5462. 2013.PubMed/NCBI View Article : Google Scholar
|
20
|
Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjöberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, et al: Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 11:76–83. 2010.PubMed/NCBI View Article : Google Scholar
|
21
|
Buse JB, Sesti G, Schmidt WE, Montanya E, Chang CT, Xu Y, Blonde L and Rosenstock J: Liraglutide Effect Action in Diabetes-6 Study Group: Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents. Diabetes Care. 33:1300–1303. 2010.PubMed/NCBI View Article : Google Scholar
|
22
|
Cui X, Li Y, Yang L, You L, Wang X, Shi C, Ji C and Guo X: Peptidome analysis of human milk from women delivering macrosomic fetuses reveals multiple means of protection for infants. Oncotarget. 7:63514–63525. 2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Dallas DC, Guerrero A, Khaldi N, Castillo PA, Martin WF, Smilowitz JT, Bevins CL, Barile D, German JB and Lebrilla CB: Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J Proteome Res. 12:2295–2304. 2013.PubMed/NCBI View Article : Google Scholar
|
24
|
Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M and Darewicz M: BIOPEP database and other programs for processing bioactive peptide sequences. J AOAC Int. 91:965–980. 2008.PubMed/NCBI
|
25
|
Wang Z, Wang H, Peng Y, Chen F, Zhao L, Li X, Qin J, Li Q, Wang B, Pan B and Guo W: A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders. Clin Chem Lab Med. 21(0869)2020.PubMed/NCBI View Article : Google Scholar
|
26
|
Dettin M, Ghezzo F, Conconi MT, Urbani L, D'Auria G, Falcigno L, Guidolin D, Nico B, Ribatti D, Di Bello C and Parnigotto PP: In vitro and in vivo pro-angiogenic effects of thymosin-beta4-derived peptides. Cell Immunol. 271:299–307. 2011.PubMed/NCBI View Article : Google Scholar
|
27
|
Soloviev M and Finch P: Peptidomics: Bridging the gap between proteome and metabolome. Proteomics. 6:744–747. 2006.PubMed/NCBI View Article : Google Scholar
|
28
|
Srinivasan M and Patel MS: Metabolic programming in the immediate postnatal period. Trends Endocrinol Metab. 19:146–152. 2008.PubMed/NCBI View Article : Google Scholar
|
29
|
Marek-Bukowiec K, Konieczny A, Ratajczyk K and Witkiewicz W: Candidate urine peptide biomarkers for IgA nephropathy: Where are we now? Dis Markers. 21(5205831)2018.PubMed/NCBI View Article : Google Scholar
|
30
|
Ishii E, Okamura J, Tsuchida M, Kobayashi M, Akiyama Y, Nakahata T, Kojima S, Hanada R, Horibe K, Sato T, et al: Infant leukemia in Japan: Clinical and biological analysis of 48 cases. Med Pediatr Oncol. 19:28–32. 1991.PubMed/NCBI View Article : Google Scholar
|
31
|
Alkhalaf A, Zürbig P, Bakker SJ, Bilo HJ, Cerna M, Fischer C, Fuchs S, Janssen B, Medek K, Mischak H, et al: Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS One. 5(e13421)2010.PubMed/NCBI View Article : Google Scholar
|
32
|
Knepper MA: Common sense approaches to urinary biomarker study design. J Am Soc Nephrol. 20:1175–1178. 2009.PubMed/NCBI View Article : Google Scholar
|
33
|
Berger J and Hinglais N: Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris). 74:694–695. 1968.(In French). PubMed/NCBI
|
34
|
Pessione E and Cirrincione S: Bioactive molecules released in food by lactic acid bacteria: Encrypted peptides and biogenic amines. Front Microbiol. 7(876)2016.PubMed/NCBI View Article : Google Scholar
|
35
|
Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB and Glassock RJ: IgA nephropathy. Nat Rev Dis Primers. 2(16001)2016.PubMed/NCBI View Article : Google Scholar
|
36
|
Woo KT, Lim CC, Foo MW, Loh HL, Jin AZ, Chin YM, Choo JC, Tan PH Chow KY, Choong LH, et al: 30-Year follow-up study of IgA nephritis in a southeast Asian population: An evaluation of the oxford histological classification. Clin Nephrol. 86:270–278. 2016.PubMed/NCBI View Article : Google Scholar
|
37
|
Tan J, Dong L, Ye D, Tang Y, Hu T, Zhong Z, Tarun P, Xu Y and Qin W: The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis. Sci Rep. 10(6062)2020.PubMed/NCBI View Article : Google Scholar
|